{"text_format":"1","workbook":"xlsx","n_sheets":4,"sheets":["1999_00-Deutsch","CF Deutsch","CF Englisch","CF_AR"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":0,"defined_names":18,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1904"}

{"sheet":"1999_00-Deutsch","index":0,"n_rows":68,"n_cols":9,"rows_kept":68,"cut":false,"hidden":true,"merged":[]}
["Asclepion-Meditec AG"]
["Kapitalflussrechnung"]
["für die Geschäftsjahre zum 30. September 2000 und 2001"]
[]
[null,null,null,null,null,null,1.95583]
[null,null,null,null,null,null,"30. September",null,"30. September"]
[null,null,null,null,null,null,2000,null,2001]
[null,null,null,null,null,null,"TDM",null,"TDM"]
[]
[]
["Cash Flow aus laufender Geschäftstätigkeit:"]
[null,"Jahresüberschuss ",null,null,null,null,3827,null,-14865]
[null,"Anpassung zur Überleitung des Jahresüberschusses/Jahresfehlbetrags"]
[null,"zur Nettoveränderung der liquiden Mittel aus laufender Geschäftstätigkeit:"]
[null,null,"Abschreibungen",null,null,null,2273,null,2334]
[null,null,"Verluste /(Gewinne) aus Abgang von Sachanlagevermögen",null,null,null,-72,null,85]
[null,null,"Zahlungsunwirksame Erträge",null,null,null,0,null,{"$f":"-(4418+5400+4271+794)","v":-14883}]
[null,null,"Zuführung zu Wertberichtigungen",null,null,null,0,null,13190]
[null,null,"Auswirkung von Wechselkursänderungen",null,null,null,-1815,null,0]
[null,null,"Anpassung Ertragsteuern für Kosten im Zusammenhang mit dem Börsengang",null,null,null,5291,null,0]
[null,null,"Latente Steuern",null,null,null,-706,null,{"$f":"-4271+505","v":-3766}]
[null,null,"Veränderung bei Vermögensgegenständen und Verbindlichkeiten:"]
[null,null,"Erhöhung der Forderungen an verbundene Unternehmen","(Erhöhung) / Verringerung der Forderungen"]
[null,null,null,null,"und Dritte",null,-23032,null,-3319]
[null,null,"Erhöhung Vorräte","Erhöhung Vorräte",null,null,-1529,null,-8688]
[null,null,"(Erhöhung) / Verringerung der aktiven Rechnungs-","(Erhöhung) / Verringerung der aktiven Rechnungs-"]
[null,null,null,null,"abgrenzung und sonstiger Vermögensgegenstände",null,-1432,null,-4835]
[null,null,"(Erhöhung) / Verringerung aktivierter Börseneinführungskosten","Erhöhung aktivierter Börseneinführungskosten",null,null,500,null,0]
[null,null,"Erhöhung / (Verringerung) der Verbindlichkeiten","Erhöhung / (Verringerung) der Verbindlichkeiten"]
[null,null,null,null,"an verbundene Unternehmen und Dritte",null,1616,null,{"$f":"-523","v":-523}]
[null,null,"Erhöhung / (Verringerung) der Rückstellungen, passiven ","Erhöhung / (Verringerung) der Rückstellungen, passiven "]
[null,null,null,null,"Rechnungsabgrenzungen und sonstigen Verbindlichkeiten",null,3088,null,1311]
[null,null,null,null,"Gesamte Anpassungen",null,{"$f":"SUM(G15:G32)-1","v":-15819},null,{"$f":"SUM(I15:I32)","v":-19094}]
[null,null,null,"    Netto-Kapitalzufluss (-abfluss) aus laufender Geschäftstätigkeit","Netto-Kapitalabfluss aus laufender Geschäftstätigkeit",null,{"$f":"+G12+G33","v":-11992},null,{"$f":"+I12+I33","v":-33959}]
["Cash Flow aus der Investitionstätigkeit:"]
[null,"Erwerb von Sachanlagevermögen",null,null,null,null,-2255,null,-17862]
[null,"Erlöse aus dem Verkauf von Sachanlagevermögen",null,null,null,null,125,null,14]
[null,"Erwerb von Minderheitenbeteiligungen an nahestehenden Unternehmen",null,null,null,null,-3548,null,-1301]
[null,"Gewährung von Darlehen",null,null,null,null,-113,null,-6984]
[null,null,null,null,"Netto-Kapitalabfluss aus Investitionstätigkeit",null,{"$f":"SUM(G36:G39)","v":-5791},null,{"$f":"SUM(I36:I39)","v":-26133}]
["Cash Flow aus Finanzierungstätigkeit:"]
[null,"Einnahmen aus der Ausgabe von Stückaktien",null,null,null,null,113994,null,0]
[null,"Aufnahme kurzfristiger Kredite",null,null,null,null,86,null,3162]
[null,"Rückzahlung kurzfristiger Kredite",null,null,null,null,-29386,null,-86]
[null,"Aufnahme langfristiger Kredite",null,null,null,null,125,null,10500]
[null,"Rückzahlung langfristiger Kredite",null,null,null,null,-1914,null,-90]
[null,"Rückzahlungen unter Leasingverträgen",null,null,null,null,-80,null,-686]
[null,"Erlöse aus Sale/Leaseback Transaktion",null,null,null,null,980,null,2681]
[null,null,null,null,"Netto-Kapitalzufluss aus Finanzierungstätigkeit",null,{"$f":"SUM(G42:G48)","v":83805},null,{"$f":"SUM(I42:I48)","v":15481}]
["Auswirkung von Wechselkursänderungen",null,null,null,null,null,-10,null,23]
["Netto-Erhöhung (Verringerung) der liquiden Mittel",null,null,null,null,null,{"$f":"+G34+G40+G49+G50-1","v":66011},null,{"$f":"+I34+I40+I49+I50","v":-44588}]
["Liquide Mittel am Jahresbeginn",null,null,null,null,null,168,null,66179]
["Liquide Mittel am Jahresende",null,null,null,null,null,{"$f":"+G51+G52","v":66179},null,{"$f":"+I51+I52","v":21591}]
[]
["Ergänzende Angaben zum Cash Flow:"]
[null,"gezahlte Zinsen",null,null,null,null,361.99465188692267,null,850]
[null,"gezahlte Steuern vom Einkommen und Ertrag",null,null,null,null,1012.3579247685126,null,1265]
[]
["Nicht zahlungswirksame Investitions- und Finanzierungstätigkeiten"]
[null,"Umwandlung der Kapitalrücklage in Grundkapital",null,null,null,null,3748.7920729306738,null,0]
[null,"Umwandlung Verbindlichkeiten für deferred shares in Grundkapital",null,null,null,null,199.91512554772143,null,0]
[null,"Umwandlung Verbindlichkeiten für deferred shares in Kapitalrücklage",null,null,null,null,399.83025109544286,null,0]
[null,"Umbuchung von Vorratsvermögen in Sachanlagevermögen",null,null,null,null,161,null,369]
[null,"Umbuchung von Forderungen aus Lieferungen und Leistungen"]
[null,null,"in Finanzanlagen",null,null,null,0,null,6260]
[]
[]
["Auf die nachfolgenden Erläuterungen im Anhang wird verwiesen"]

{"sheet":"CF Deutsch","index":1,"n_rows":94,"n_cols":9,"rows_kept":94,"cut":false,"hidden":false,"merged":[[73,1,73,4],[72,1,72,4],[2,0,2,8],[1,0,1,8],[70,1,70,4],[56,1,56,4],[29,1,29,4],[71,1,71,4],[61,2,61,4]]}
[]
["Carl Zeiss Meditec AG"]
["Konzern-Kapitalflussrechnung (IFRS) 1. Oktober 2013 bis 31. Dezember 2013"]
[]
[null,null,null,null,null,null,"Geschäftsjahr 2013/2014",null,"Geschäftsjahr 2012/2013*"]
[null,null,null,null,null,null,"1. Oktober 2013 -",null,"1. Oktober 2012 -"]
[null,null,null,null,null,"Anhang","31. Dezember 2013",null,"31. Dezember 2012"]
[null,null,null,null,null,null,"€ Tsd.",null,{"$f":"+G8","v":"€ Tsd."}]
[]
["Cashflow aus der gewöhnlichen Geschäftstätigkeit:"]
[]
[null,"Konzernergebnis",null,null,null,null,{"$f":"20098+1326","v":21424},null,25186.764239793971]
[]
[null,"Anpassung zur Überleitung des Konzernergebnisses"]
[null,"zur Nettoveränderung der liquiden Mittel aus laufender Geschäftstätigkeit:"]
[]
[null,"Ertragsteueraufwand",null,null,null,"(8)",10413,null,13117.76151284242]
[null,"Zinserträge / Zinsaufwendungen",null,null,null,"(7)",877,null,606]
[null,"Ergebnis aus At-Equity bewerteten Finanzanlagen",null,null,null,"(7)",0,null,0]
[null,"Ergebnis aus sonstigen Beteiligungen",null,null,null,"(7)",0,null,0]
[null,"Abschreibungen",null,null,null,"(12) (13)",4046,null,4267]
[null,"Wertaufholungen",null,null,null,"(13)",null,null,0]
[null,"Abschreibungen auf Finanzanlagen",null,null,null,"(7)",null,null,0]
[null,"Gewinne/Verluste aus Abgang/Abwertung von Anlagevermögen",null,null,null,null,-190,null,-61]
[null,"Erhaltene Dividenden",null,null,null,null,0,null,0]
[null,"Erhaltene Zinsen",null,null,null,null,116,null,203]
[null,"Gezahlte Zinsen",null,null,null,null,-289,null,-461]
[null,"Steuererstattungen",null,null,null,null,985,null,170]
[null,"Gezahlte Ertragsteuern",null,null,null,null,-15715,null,-9015]
[null,"Einzahlungen aus der Übernahme von Pensionsverpflichtungen \ndurch die Carl Zeiss Meditec Japan"]
[]
[null,"Veränderungen des Working Capitals:"]
[]
[null,null,"Forderungen aus Lieferungen und Leistungen",null,null,"(18)",15928,null,-2552]
[null,null,"Vorräte",null,null,"(17)",-15546,null,-6845]
[null,null,"Sonstige Vermögenswerte",null,null,"(16) (19) (20)",-5787,null,-5448]
[null,null,"Verbindlichkeiten aus Lieferungen und Leistungen",null,null,null,-16810,null,-10271]
[null,null,"Ertragsteuerverbindlichkeiten",null,null,null,null,null,0]
[null,null,"Rückstellungen und finanzielle Verbindlichkeiten",null,null,"(23) (24) (26)",-7117,null,-7601.5257526363921]
[null,null,"Sonstige Verbindlichkeiten",null,null,"(27)",1635,null,5717]
[]
[null,"Gesamte Anpassungen",null,null,null,null,{"$f":"SUM(G17:G41)","v":-27454},null,{"$f":"SUM(I17:I41)","v":-18173.764239793971}]
[null,"Netto-Kapitalzufluss aus der gewöhnlichen Geschäftstätigkeit",null,null,null,null,{"$f":"+G12+G42","v":-6030},null,{"$f":"+I12+I42","v":7013}]
[]
["Cashflow aus der Investitionstätigkeit:"]
[]
[null,"Veränderung liquide Mittel mit Verfügungsbeschränkung",null,null,null,null,0,null,0]
[null,"Investitionen in Sachanlagen",null,null,null,"(13)",-2538,null,-1489]
[null,"Investitionen in sonstige immaterielle Vermögenswerte",null,null,null,"(12)",-64,null,-81]
[null,"Investitionen in Planvermögen",null,null,null,"(24)",null,null,0]
[null,"Erlöse aus dem Verkauf von Anlagevermögen",null,null,null,null,403,null,56]
[null,"Erlöse aus der Liquidation von At-Equity Beteiligungen",null,null,null,null,null,null,0]
[null,"Einzahlungen aus Festgeldanlagen",null,null,null,null,null,null,0]
[null,"Auszahlungen für Festgeldanlagen",null,null,null,null,null,null,0]
[null,"Auszahlungen aus der Ausgabe von Ausleihungen"]
[null,"Verkauf von Wertpapieren",null,null,null,"(28)"]
[null,"Erwerb des chirurgischen Geschäftes (Carl Zeiss Surgical GmbH, Carl Zeiss Surgical Inc.) gegen Gewährung von Aktien"]
[null,"Erwerb IOL/ OVD - Geschäftes IMEX Clinic S.L., Spanien",null,null,null,"(3)",-716,null,-1907]
[null,"Erwerb Optronik A.S., Türkei, abzgl. erhaltener Finanzmittel",null,null,null,"(2b)",-10843,null,0]
[null,"Kapitalherabsetzung At-Equity Beteiligung",null,null,null,null,null,null,0]
[null,"Erwerb konsolidierter Unternehmen / Geschäftsbetriebe abzgl. erhaltener Finanzmittel",null,null,null,"(3)",null,null,0]
[]
[null,"Einzahlungen aus der Tilgung von einem ehemaligen Gesellschafter (Acri.Tec) gewährten Darlehen ",null,null,null,"(3)",null,null,0]
[null,"Verkauf Ioltech Italia S.R.L.",null,null,null,null,null,null,0]
[]
[null,"Netto-Kapitalabfluss aus der Investitionstätigkeit",null,null,null,null,{"$f":"SUM(G47:G63)","v":-13758},null,{"$f":"SUM(I47:I63)","v":-3421}]
[]
["Cashflow aus der Finanzierungstätigkeit:"]
[null,"Aufnahme/(Rückzahlung) der kurzfristigen Kredite",null,null,null,null,160,null,132]
[null,"Aufnahme/(Rückzahlung) der langfristigen Kredite",null,null,null,"(25)",-163,null,-127]
[null,"Rückzahlungen von kurzfristigen Darlehen von nahe stehenden Unternehmen",null,null,null,"(35)"]
[null,"Auszahlung aus der Gewährung kurzfristigen Darlehen an nahe stehenden Unternehmen"]
[null,"Rückzahlungen von langfristigen Darlehen von nahe stehenden Unternehmen",null,null,null,"(26) (35)"]
[null,"Einzahlungen aus der Übernahme von Pensionsverpflichtungen durch die Carl Zeiss Meditec Japan"]
[null,"(Zunahme)/Abnahme der Forderungen aus Finanzausgleich",null,null,null,"(2t) (34)",22075,null,6512]
[null,"Zunahme/(Abnahme) der Verbindlichkeiten aus Finanzausgleich",null,null,null,"(2t) (34)",-460,null,-6941]
[null,"Rückzahlung von Wandelschuldverschreibungen der Ioltech"]
[null,"Veränderung der Verbindlichkeiten aus Finanzierungsleasing",null,null,null,"(29)",-457,null,-437]
[null,"Einnahmen aus Kapitalerhöhung",null,null,null,"(24)"]
[null,"Kosten der Kapitalerhöhung (vor Steuern)",null,null,null,"(24)"]
[null,"Dividendenzahlung an Minderheitsaktionäre der Carl Zeiss Meditec Co. Ltd. (Japan)",null,null,null,"(13)"]
[null,"Dividendenzahlung an die Aktionäre der Carl Zeiss Meditec AG",null,null,null,"(10)"]
[null,"Erwerb von Anteilen nicht-beherrschender Gesellschafter"]
[]
[null,"Netto-Kapitalzufluss/(-abfluss) aus der Finanzierungstätigkeit",null,null,null,null,{"$f":"SUM(G68:G84)","v":21155},null,{"$f":"SUM(I68:I84)","v":-861}]
[]
["Einfluss von Wechselkursänderungen auf Zahlungsmittel und Zahlungsmitteläquivalente",null,null,null,null,null,-369,null,-795]
["Zunahme/(Abnahme) der Zahlungsmittel und Zahlungsmitteläquivalente",null,null,null,null,null,998,null,{"$f":"+I43+I66+I85+I87","v":1936}]
["Zahlungsmittel und Zahlungsmitteläquivalente am Beginn des Berichtszeitraumes",null,null,null,null,"(21)",6286,null,9526]
["Zahlungsmittel und Zahlungsmitteläquivalente am Ende des Berichtszeitraumes",null,null,null,null,"(21)",{"$f":"+G88+G89","v":7284},null,{"$f":"+I88+I89","v":11462}]
[]
[]
["* Das Vorjahr wurde aufgrund des geänderten IAS 19 angepasst."]
["Der nachfolgende Konzernanhang ist integraler Bestandteil des ungeprüften Konzernabschlusses."]

{"sheet":"CF Englisch","index":2,"n_rows":94,"n_cols":9,"rows_kept":94,"cut":false,"hidden":false,"merged":[[2,0,2,8],[1,0,1,8],[56,1,56,4],[73,1,73,4],[29,2,29,5],[60,2,60,4]]}
[]
["Carl Zeiss Meditec AG"]
["Consolidated statement of cash flows (IFRS) for the period \nfrom 1 October 2013 to 31 December 2013"]
[]
[null,null,null,null,null,null,"Financial year 2013/2014",null,"Financial year 2012/2013*"]
[null,null,null,null,null,null,"1 October 2013 -",null,"1 October 2012 -"]
[null,null,null,null,null,"Note","31 December 2013",null,"31 December 2012"]
[null,null,null,null,null,null,"€ '000",null,{"$f":"+G8","v":"€ '000"}]
[]
["Cash flows from operating activities:",null,null,null,null,{"$f":"IF('CF Deutsch'!F10<>\"\",'CF Deutsch'!F10,\"\")","v":""}]
[null,null,null,null,null,{"$f":"IF('CF Deutsch'!F11<>\"\",'CF Deutsch'!F11,\"\")","v":""}]
[null,"Net income",null,null,null,{"$f":"IF('CF Deutsch'!F12<>\"\",'CF Deutsch'!F12,\"\")","v":""},{"$f":"+'CF Deutsch'!G12","v":21424},null,{"$f":"+'CF Deutsch'!I12","v":25186.764239793971}]
[null,null,null,null,null,{"$f":"IF('CF Deutsch'!F13<>\"\",'CF Deutsch'!F13,\"\")","v":""}]
[null,"Adjustments to reconcile net income to net cash provided by / (used in)",null,null,null,{"$f":"IF('CF Deutsch'!F14<>\"\",'CF Deutsch'!F14,\"\")","v":""}]
[null,"operating activities",null,null,null,{"$f":"IF('CF Deutsch'!F15<>\"\",'CF Deutsch'!F15,\"\")","v":""}]
[null,null,null,null,null,{"$f":"IF('CF Deutsch'!F16<>\"\",'CF Deutsch'!F16,\"\")","v":""}]
[null,null,"Income tax expenses",null,null,{"$f":"IF('CF Deutsch'!F17<>\"\",'CF Deutsch'!F17,\"\")","v":"(8)"},{"$f":"+'CF Deutsch'!G17","v":10413},null,{"$f":"+'CF Deutsch'!I17","v":13117.76151284242}]
[null,null,"Interest income / expenses ",null,null,{"$f":"+'CF Deutsch'!F18","v":"(7)"},{"$f":"+'CF Deutsch'!G18","v":877},null,{"$f":"+'CF Deutsch'!I18","v":606}]
[null,null,"Results from investments accounted for using the equity method",null,null,{"$f":"+'CF Deutsch'!F19","v":"(7)"},{"$f":"+'CF Deutsch'!G19","v":0},null,{"$f":"+'CF Deutsch'!I19","v":0}]
[null,null,"Result from other participations",null,null,{"$f":"+'CF Deutsch'!F20","v":"(7)"},{"$f":"+'CF Deutsch'!G20","v":0},null,{"$f":"+'CF Deutsch'!I20","v":0}]
[null,null,"Depreciation and amortisation",null,null,{"$f":"IF('CF Deutsch'!F21<>\"\",'CF Deutsch'!F21,\"\")","v":"(12) (13)"},{"$f":"+'CF Deutsch'!G21","v":4046},null,{"$f":"+'CF Deutsch'!I21","v":4267}]
[null,null,"Appreciation and write-ups",null,null,{"$f":"IF('CF Deutsch'!F22<>\"\",'CF Deutsch'!F22,\"\")","v":"(13)"},{"$f":"+'CF Deutsch'!G22","v":0},null,{"$f":"+'CF Deutsch'!I22","v":0}]
[null,null,"Impairment of financial assets",null,null,{"$f":"IF('CF Deutsch'!F23<>\"\",'CF Deutsch'!F23,\"\")","v":"(7)"},{"$f":"'CF Deutsch'!G23","v":0},null,{"$f":"'CF Deutsch'!I23","v":0}]
[null,null,"Gains / losses on disposal of fixed assets ",null,null,{"$f":"IF('CF Deutsch'!F24<>\"\",'CF Deutsch'!F24,\"\")","v":""},{"$f":"+'CF Deutsch'!G24","v":-190},null,{"$f":"+'CF Deutsch'!I24","v":-61}]
[null,null,"Dividends received",null,null,{"$f":"IF('CF Deutsch'!F25<>\"\",'CF Deutsch'!F25,\"\")","v":""},{"$f":"+'CF Deutsch'!G25","v":0},null,{"$f":"+'CF Deutsch'!I25","v":0}]
[null,null,"Interest received",null,null,{"$f":"IF('CF Deutsch'!F26<>\"\",'CF Deutsch'!F26,\"\")","v":""},{"$f":"+'CF Deutsch'!G26","v":116},null,{"$f":"+'CF Deutsch'!I26","v":203}]
[null,null,"Interest paid",null,null,{"$f":"IF('CF Deutsch'!F27<>\"\",'CF Deutsch'!F27,\"\")","v":""},{"$f":"+'CF Deutsch'!G27","v":-289},null,{"$f":"+'CF Deutsch'!I27","v":-461}]
[null,null,"Income tax reimbursement",null,null,null,{"$f":"+'CF Deutsch'!G28","v":985},null,{"$f":"+'CF Deutsch'!I28","v":170}]
[null,null,"Income taxes paid",null,null,{"$f":"IF('CF Deutsch'!F29<>\"\",'CF Deutsch'!F29,\"\")","v":""},{"$f":"+'CF Deutsch'!G29","v":-15715},null,{"$f":"+'CF Deutsch'!I29","v":-9015}]
[null,null,"Cash inflow from transfer of provisions to Carl Zeiss Meditec Japan",null,null,null,{"$f":"+'CF Deutsch'!G30","v":0},null,{"$f":"+'CF Deutsch'!I30","v":0}]
[]
[null,"Changes in working capital:",null,null,null,{"$f":"IF('CF Deutsch'!F32<>\"\",'CF Deutsch'!F32,\"\")","v":""}]
[null,null,null,null,null,{"$f":"IF('CF Deutsch'!F33<>\"\",'CF Deutsch'!F33,\"\")","v":""}]
[null,null,"Trade receivables",null,null,{"$f":"IF('CF Deutsch'!F34<>\"\",'CF Deutsch'!F34,\"\")","v":"(18)"},{"$f":"+'CF Deutsch'!G34","v":15928},null,{"$f":"+'CF Deutsch'!I34","v":-2552}]
[null,null,"Inventories",null,null,{"$f":"IF('CF Deutsch'!F35<>\"\",'CF Deutsch'!F35,\"\")","v":"(17)"},{"$f":"+'CF Deutsch'!G35","v":-15546},null,{"$f":"+'CF Deutsch'!I35","v":-6845}]
[null,null,"Other assets",null,null,{"$f":"IF('CF Deutsch'!F36<>\"\",'CF Deutsch'!F36,\"\")","v":"(16) (19) (20)"},{"$f":"+'CF Deutsch'!G36","v":-5787},null,{"$f":"+'CF Deutsch'!I36","v":-5448}]
[null,null,"Trade payables",null,null,{"$f":"IF('CF Deutsch'!F37<>\"\",'CF Deutsch'!F37,\"\")","v":""},{"$f":"+'CF Deutsch'!G37","v":-16810},null,{"$f":"+'CF Deutsch'!I37","v":-10271}]
[null,null,"Income tax liabilities","Erhöhung Vorräte",null,{"$f":"IF('CF Deutsch'!F38<>\"\",'CF Deutsch'!F38,\"\")","v":""},{"$f":"+'CF Deutsch'!G38","v":0},null,{"$f":"+'CF Deutsch'!I38","v":0}]
[null,null,"Provisions and financial liabilities",null,null,{"$f":"IF('CF Deutsch'!F39<>\"\",'CF Deutsch'!F39,\"\")","v":"(23) (24) (26)"},{"$f":"+'CF Deutsch'!G39","v":-7117},null,{"$f":"+'CF Deutsch'!I39","v":-7601.5257526363921}]
[null,null,"Other liabilities",null,null,{"$f":"IF('CF Deutsch'!F40<>\"\",'CF Deutsch'!F40,\"\")","v":"(27)"},{"$f":"+'CF Deutsch'!G40","v":1635},null,{"$f":"+'CF Deutsch'!I40","v":5717}]
[]
[null,null,null,null,null,{"$f":"IF('CF Deutsch'!F41<>\"\",'CF Deutsch'!F41,\"\")","v":""}]
[null,"Total adjustments",null,null,null,{"$f":"IF('CF Deutsch'!F42<>\"\",'CF Deutsch'!F42,\"\")","v":""},{"$f":"+'CF Deutsch'!G42","v":-27454},null,{"$f":"+'CF Deutsch'!I42","v":-18173.764239793971}]
[null,"Net cash provided by operating activities",null,null,null,{"$f":"IF('CF Deutsch'!F43<>\"\",'CF Deutsch'!F43,\"\")","v":""},{"$f":"+'CF Deutsch'!G43","v":-6030},null,{"$f":"+'CF Deutsch'!I43","v":7013}]
[null,null,null,null,null,{"$f":"IF('CF Deutsch'!F44<>\"\",'CF Deutsch'!F44,\"\")","v":""}]
["Cash flows from investing activities:",null,null,null,null,{"$f":"IF('CF Deutsch'!F45<>\"\",'CF Deutsch'!F45,\"\")","v":""}]
[null,null,null,null,null,{"$f":"IF('CF Deutsch'!F46<>\"\",'CF Deutsch'!F46,\"\")","v":""}]
[null,"Change of restricted cash",null,null,null,{"$f":"IF('CF Deutsch'!F47<>\"\",'CF Deutsch'!F47,\"\")","v":""},{"$f":"+'CF Deutsch'!G47","v":0},null,{"$f":"+'CF Deutsch'!I47","v":0}]
[null,"Investment in property, plant and equipment",null,null,null,{"$f":"IF('CF Deutsch'!F48<>\"\",'CF Deutsch'!F48,\"\")","v":"(13)"},{"$f":"+'CF Deutsch'!G48","v":-2538},null,{"$f":"+'CF Deutsch'!I48","v":-1489}]
[null,"Investment in intangible assets",null,null,null,{"$f":"IF('CF Deutsch'!F49<>\"\",'CF Deutsch'!F49,\"\")","v":"(12)"},{"$f":"+'CF Deutsch'!G49","v":-64},null,{"$f":"+'CF Deutsch'!I49","v":-81}]
[null,"Investment in plan assets ",null,null,null,{"$f":"IF('CF Deutsch'!F50<>\"\",'CF Deutsch'!F50,\"\")","v":"(24)"},{"$f":"+'CF Deutsch'!G50","v":0},null,{"$f":"+'CF Deutsch'!I50","v":0}]
[null,"Proceeds from fixed assets",null,null,null,{"$f":"IF('CF Deutsch'!F51<>\"\",'CF Deutsch'!F51,\"\")","v":""},{"$f":"'CF Deutsch'!G51","v":403},null,{"$f":"'CF Deutsch'!I51","v":56}]
[null,"Proceeds from liquidation of investments accounted for using the equity method",null,null,null,{"$f":"IF('CF Deutsch'!F52<>\"\",'CF Deutsch'!F52,\"\")","v":""},{"$f":"'CF Deutsch'!G52","v":0},null,{"$f":"'CF Deutsch'!I52","v":0}]
[null,"Proceeds from fixed term deposits",null,null,null,{"$f":"IF('CF Deutsch'!F53<>\"\",'CF Deutsch'!F53,\"\")","v":""},{"$f":"'CF Deutsch'!G53","v":0},null,{"$f":"'CF Deutsch'!I53","v":0}]
[null,"Investments in fixed term deposits",null,null,null,{"$f":"IF('CF Deutsch'!F54<>\"\",'CF Deutsch'!F54,\"\")","v":""},{"$f":"'CF Deutsch'!G54","v":0},null,{"$f":"'CF Deutsch'!I54","v":0}]
[null,"Sale of securities",null,null,null,{"$f":"IF('CF Deutsch'!F55<>\"\",'CF Deutsch'!F55,\"\")","v":""},{"$f":"'CF Deutsch'!G56","v":0},null,{"$f":"'CF Deutsch'!I56","v":0}]
[null,"Acquisition of the surgical business (Carl Zeiss Surgical GmbH, Carl Zeiss Surgical Inc.) against grant of shares",null,null,null,{"$f":"IF('CF Deutsch'!F56<>\"\",'CF Deutsch'!F56,\"\")","v":"(28)"},{"$f":"'CF Deutsch'!G57","v":0},null,{"$f":"'CF Deutsch'!I57","v":0}]
[null,"Acquisition of IOL/ OVD-business IMEX Clinic S.L., Spain",null,null,null,{"$f":"+'CF Deutsch'!F58","v":"(3)"},{"$f":"+'CF Deutsch'!G58","v":-716},null,{"$f":"+'CF Deutsch'!I58","v":-1907}]
[null,"Acquisition Optronik A.S., Turkey, net of cash aquired",null,null,null,{"$f":"IF('CF Deutsch'!F58<>\"\",'CF Deutsch'!F58,\"\")","v":"(3)"},{"$f":"+'CF Deutsch'!G59","v":-10843},null,{"$f":"+'CF Deutsch'!I59","v":0}]
[null,"Acquisition of consolidated companies / businesses, net of cash acquired",null,null,null,{"$f":"IF('CF Deutsch'!F59<>\"\",'CF Deutsch'!F59,\"\")","v":"(2b)"},{"$f":"'CF Deutsch'!G61","v":0},null,{"$f":"'CF Deutsch'!I61","v":0}]
[null,null,"(2009/2010: Carl Zeiss Meditec S.A.S.: € 60 thsd.)",null,null,{"$f":"IF('CF Deutsch'!F60<>\"\",'CF Deutsch'!F60,\"\")","v":""}]
[]
[null,"Cash receipts from repayment of loans made to a former shareholder (Acri.Tec)",null,null,null,{"$f":"+'CF Deutsch'!F63","v":"(3)"},{"$f":"+'CF Deutsch'!G63","v":0},null,{"$f":"+'CF Deutsch'!I63","v":0}]
[null,"Sale of Ioltech Italia S.R.L.",null,null,null,null,null,null,{"$f":"+'CF Deutsch'!I64","v":0}]
[null,null,null,null,null,{"$f":"IF('CF Deutsch'!F65<>\"\",'CF Deutsch'!F65,\"\")","v":""}]
[null,"Net cash used in investing activities",null,null,null,{"$f":"IF('CF Deutsch'!F66<>\"\",'CF Deutsch'!F66,\"\")","v":""},{"$f":"+'CF Deutsch'!G66","v":-13758},null,{"$f":"+'CF Deutsch'!I66","v":-3421}]
[null,null,null,null,null,{"$f":"IF('CF Deutsch'!F67<>\"\",'CF Deutsch'!F67,\"\")","v":""}]
["Cash flows from financing activities:",null,null,null,null,{"$f":"IF('CF Deutsch'!F68<>\"\",'CF Deutsch'!F68,\"\")","v":""}]
[null,"Proceeds from/(repayment of) short-term debt",null,null,null,{"$f":"IF('CF Deutsch'!F69<>\"\",'CF Deutsch'!F69,\"\")","v":""},{"$f":"+'CF Deutsch'!G69","v":160},null,{"$f":"+'CF Deutsch'!I69","v":132}]
[null,"Proceeds from/(repayment of) noncurrent financial liabilities",null,null,null,{"$f":"IF('CF Deutsch'!F70<>\"\",'CF Deutsch'!F70,\"\")","v":"(25)"},{"$f":"+'CF Deutsch'!G70","v":-163},null,{"$f":"+'CF Deutsch'!I70","v":-127}]
[null,"Repayments from current loans from related parties",null,null,null,{"$f":"IF('CF Deutsch'!F71<>\"\",'CF Deutsch'!F71,\"\")","v":"(35)"},{"$f":"+'CF Deutsch'!G71","v":0},null,{"$f":"+'CF Deutsch'!I71","v":0}]
[null,"Payment from granting of current loans to related parties",null,null,null,null,null,null,{"$f":"+'CF Deutsch'!I72","v":0}]
[null,"Repayments from noncurrent loans from related parties",null,null,null,{"$f":"IF('CF Deutsch'!F73<>\"\",'CF Deutsch'!F73,\"\")","v":"(26) (35)"},{"$f":"+'CF Deutsch'!G73","v":0},null,{"$f":"+'CF Deutsch'!I73","v":0}]
[null,"Cash inflow from transfer of provisions to Carl Zeiss Meditec Japan Co. Ltd.",null,null,null,null,{"$f":"+'CF Deutsch'!G74","v":0},null,{"$f":"+'CF Deutsch'!I74","v":0}]
[null,"(Increase) / decrease in treasury receivables",null,null,null,{"$f":"IF('CF Deutsch'!F75<>\"\",'CF Deutsch'!F75,\"\")","v":"(2t) (34)"},{"$f":"'CF Deutsch'!G75","v":22075},null,{"$f":"'CF Deutsch'!I75","v":6512}]
[null,"Increase / (decrease) in treasury payables",null,null,null,{"$f":"+'CF Deutsch'!F76","v":"(2t) (34)"},{"$f":"+'CF Deutsch'!G76","v":-460},null,{"$f":"'CF Deutsch'!I76","v":-6941}]
[null,"Repayment of convertible bonds issued by Ioltech",null,null,null,{"$f":"IF('CF Deutsch'!F77<>\"\",'CF Deutsch'!F77,\"\")","v":""},{"$f":"'CF Deutsch'!G77","v":0},null,{"$f":"'CF Deutsch'!I77","v":0}]
[null,"Change of leasing liabilities",null,null,null,{"$f":"IF('CF Deutsch'!F78<>\"\",'CF Deutsch'!F78,\"\")","v":"(29)"},{"$f":"+'CF Deutsch'!G78","v":-457},null,{"$f":"+'CF Deutsch'!I78","v":-437}]
[null,"Proceeds from capital increase",null,null,null,{"$f":"IF('CF Deutsch'!F79<>\"\",'CF Deutsch'!F79,\"\")","v":"(24)"},{"$f":"+'CF Deutsch'!G79","v":0},null,{"$f":"+'CF Deutsch'!I79","v":0}]
[null,"Costs from capital increase (net of taxes)",null,null,null,{"$f":"IF('CF Deutsch'!F80<>\"\",'CF Deutsch'!F80,\"\")","v":"(24)"},{"$f":"+'CF Deutsch'!G80","v":0},null,{"$f":"+'CF Deutsch'!I80","v":0}]
[null,"Dividend payments to minority shareholders of Carl Zeiss Meditec Co. Ltd. (Japan)",null,null,null,{"$f":"IF('CF Deutsch'!F81<>\"\",'CF Deutsch'!F81,\"\")","v":"(13)"},{"$f":"+'CF Deutsch'!G81","v":0},null,{"$f":"+'CF Deutsch'!I81","v":0}]
[null,"Dividend payments to shareholders of Carl Zeiss Meditec AG",null,null,null,{"$f":"IF('CF Deutsch'!F82<>\"\",'CF Deutsch'!F82,\"\")","v":"(10)"},{"$f":"+'CF Deutsch'!G82","v":0},null,{"$f":"+'CF Deutsch'!I82","v":0}]
[null,"Acquisition of non-controlling interests",null,null,null,{"$f":"IF('CF Deutsch'!F83<>\"\",'CF Deutsch'!F83,\"\")","v":""},{"$f":"+'CF Deutsch'!G83","v":0},null,{"$f":"+'CF Deutsch'!I83","v":0}]
[null,null,null,null,null,{"$f":"IF('CF Deutsch'!F84<>\"\",'CF Deutsch'!F84,\"\")","v":""}]
[null,"Net cash provided by/ (used in) financing activities",null,null,null,{"$f":"IF('CF Deutsch'!F85<>\"\",'CF Deutsch'!F85,\"\")","v":""},{"$f":"+'CF Deutsch'!G85","v":21155},null,{"$f":"+'CF Deutsch'!I85","v":-861}]
[null,null,null,null,null,{"$f":"IF('CF Deutsch'!F86<>\"\",'CF Deutsch'!F86,\"\")","v":""}]
["Effect of exchange rate fluctuation on cash and cash equivalents",null,null,null,null,{"$f":"IF('CF Deutsch'!F87<>\"\",'CF Deutsch'!F87,\"\")","v":""},{"$f":"+'CF Deutsch'!G87","v":-369},null,{"$f":"+'CF Deutsch'!I87","v":-795}]
["Net increase / (decrease)  in cash and cash equivalents",null,null,null,null,{"$f":"IF('CF Deutsch'!F88<>\"\",'CF Deutsch'!F88,\"\")","v":""},{"$f":"+'CF Deutsch'!G88","v":998},null,{"$f":"+'CF Deutsch'!I88","v":1936}]
["Cash and cash equivalents, beginning of reporting period",null,null,null,null,{"$f":"IF('CF Deutsch'!F89<>\"\",'CF Deutsch'!F89,\"\")","v":"(21)"},{"$f":"+'CF Deutsch'!G89","v":6286},null,{"$f":"+'CF Deutsch'!I89","v":9526}]
["Cash and cash equivalents, end of reporting period",null,null,null,null,{"$f":"IF('CF Deutsch'!F90<>\"\",'CF Deutsch'!F90,\"\")","v":"(21)"},{"$f":"+'CF Deutsch'!G90","v":7284},null,{"$f":"+'CF Deutsch'!I90","v":11462}]
[]
[]
["* The prior-year figures are adjusted due to amended IAS 19 regulations."]
["The following notes to the consolidated financial statements are an integral part of the unaudited consolidated financial statements."]

{"sheet":"CF_AR","index":3,"n_rows":27,"n_cols":8,"rows_kept":27,"cut":false,"hidden":true,"merged":[[0,0,0,7],[1,0,1,7],[2,0,2,7]]}
["Carl Zeiss Meditec AG"]
["selected positions"]
["Consolidated statement of cash flow (US GAAP)"]
[]
[null,null,null,null,null,"1. October 2001 -",null,"1. October 2002 -"]
[null,null,null,null,null,"30. June 2002",null,"30. June 2003"]
[null,null,null,null,null,"Tsd. Euro",null,"Tsd. Euro"]
[]
[]
["Cash flow from operating activities"]
[null,null,"Net income",null,null,{"$f":"+'CF Deutsch'!G12","v":21424},null,{"$f":"+'CF Deutsch'!I12","v":25186.764239793971}]
[null,null,"Loss on disposal of discontinued operations",null,null,{"$f":"+'CF Deutsch'!#REF!","v":{"$error":"#REF!"}},null,{"$f":"+'CF Deutsch'!#REF!","v":{"$error":"#REF!"}}]
[null,null,"Depreciation and amortisation",null,null,{"$f":"+'CF Deutsch'!G21","v":4046},null,{"$f":"+'CF Deutsch'!I21","v":4267}]
[null,null,"Trade accounts receivable",null,null,{"$f":"+'CF Deutsch'!G34","v":15928},null,{"$f":"+'CF Deutsch'!I34","v":-2552}]
[null,null,"Inventories",null,null,{"$f":"+'CF Deutsch'!G35","v":-15546},null,{"$f":"+'CF Deutsch'!I35","v":-6845}]
[null,null,"Trade accounts payable",null,null,{"$f":"+'CF Deutsch'!G37","v":-16810},null,{"$f":"+'CF Deutsch'!I37","v":-10271}]
[null,null,"Accrued tax expenses","Erhöhung Vorräte",null,{"$f":"+'CF Deutsch'!G38","v":0},null,{"$f":"+'CF Deutsch'!I38","v":0}]
[null,null,"Other accrued expenses and liabilities","(Erhöhung) / Verringerung der aktiven Rechnungs-",null,{"$f":"+'CF Deutsch'!G39","v":-7117},null,{"$f":"+'CF Deutsch'!I39","v":-7601.5257526363921}]
[]
["Cash flow from investing activities",null,null,null,null,{"$f":"+'CF Deutsch'!G66","v":-13758},null,{"$f":"+'CF Deutsch'!I66","v":-3421}]
[]
["Cash flow from financing activities"]
[null,"Proceeds from issuance of short-term debt from related parties",null,null,null,{"$f":"+'CF Deutsch'!G71","v":0},null,{"$f":"+'CF Deutsch'!I71","v":0}]
[null,"Increase / (decrease) in liabilities due to Treasury",null,null,null,{"$f":"+'CF Deutsch'!#REF!","v":{"$error":"#REF!"}},null,{"$f":"+'CF Deutsch'!#REF!","v":{"$error":"#REF!"}}]
[null,"(Increase) / decrease in accounts receivable due to Treasury",null,null,null,{"$f":"+'CF Deutsch'!G75","v":22075},null,{"$f":"+'CF Deutsch'!I75","v":6512}]
[]
["Net increase in cash (compared to Oct 1)",null,null,null,null,{"$f":"+'CF Deutsch'!G88","v":998},null,{"$f":"+'CF Deutsch'!I88","v":1936}]